ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261305.1	Elesclomol	Breast invasive carcinoma	0.048267486	Resistant
ENSG00000261305.1	Elesclomol	Chronic Lymphocytic Leukemia	0.007336257	Sensitive